DWIGHT Wesley J.
No ORCID on file
· 51 papers in corpus
· active 2000-2009
Frequent coauthors
- HAVIV FORTUNA 34
- GREER JONATHAN 34
- NICHOLS Charles J. 34
- HUANG CHARLES Q 17
- TUCCI FABIO C 17
- WU DONGPEI 17
- CHEN CHEN 17
- WADE WARREN 17
- CHEN YONGSHENG 17
- GUO ZHIQIANG 17
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…